Effectiveness and safety of non-tumor necrosis factor inhibitor therapy for anti-human T-cell leukemia virus type 1 antibody-positive rheumatoid arthritis.
Mod Rheumatol. 2020 Nov 27:1-12. doi: 10.1080/14397595.2020.1847802. Online ahead of print.
Mod Rheumatol. 2020.
PMID: 33161771